Amwell Q2 revenue $70.9M, net loss $19.5M; cuts FY2025 revenue guidance to $245M-$250M

American Well Corp

2025-Q2 EPS reported -$2.43 vs consensus -$1.78 ▼ miss (-36.8%)

Revenue $70.9M (subscription $40.4M, AMG visits $22.8M); gross margin 56.1%.
Net loss $19.5M (vs $18.4M Q1); Adj. EBITDA loss improved to $4.7M from $12.2M Q1.
Added Florida Blue health plan; extended US Defense Health Agency contract.
FY2025 revenue guidance lowered to $245M-$250M from $250M-$260M; Adj. EBITDA narrowed to ($50M)-($45M).
Q3 2025 guidance: revenue $53M-$56M, Adj. EBITDA loss ($15M)-($13M).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.